|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_on1080075666 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
181222s2018 ts o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d OCLCQ
|d N$T
|d OCLCF
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 1079004924
|
| 020 |
|
|
|a 1681086271
|
| 020 |
|
|
|a 9781681086279
|q (electronic bk.)
|
| 029 |
1 |
|
|a AU@
|b 000070391934
|
| 035 |
|
|
|a (OCoLC)1080075666
|z (OCoLC)1079004924
|
| 050 |
|
4 |
|a RC267
|
| 082 |
0 |
4 |
|a 616.994072
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Rahman, Atta-ur-,
|d 1942-
|1 https://id.oclc.org/worldcat/entity/E39PBJx8yHRKtPYdRvxrTpJYyd
|
| 245 |
1 |
0 |
|a Topics in Anti-Cancer Research
|
| 260 |
|
|
|a Sharjah :
|b Bentham Science Publishers,
|c 2018.
|
| 300 |
|
|
|a 1 online resource (246 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Cover; Title; Biblography; End User License Agreement; Contents; Preface; Introduction; List of Contributors; The Role of ncRNAs in Human Cancer and its Related Patents; María I. Navarro-Mendoza1, Carlos Pérez-Arques1, Laura Murcia1, Alfonso F. López-Martínez2 and Francisco E. Nicolás1,*; 1. INTRODUCTION; 2. SMALL NCRNAS: MIRNAS, PIRNAS, TIRNAS, SNORNAS AND PARNAS; 2.1. miRNAs; 2.2. piRNAs; 2.3. tiRNAs; 2.4. snoRNAs; 2.5. Small Promoter Associated RNAs; 2.6. Other Small ncRNAs; 3. LONG NCRNAS: LINCRNAS, T-UCRS, CERNAS AND OTHER LNCRNAS; 3.1. LincRNAs; 3.2. T-UCRs; 3.3. CeRNAs
|
| 505 |
8 |
|
|a 3.4. Other lncRNAsCURRENT & FUTURE DEVELOPMENTS; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; DISCLOSURE; REFERENCES; Taxol To Nanotaxol: A Journey Towards Enhanced Drug Delivery; Tanvi Kaku1, Aiswarya Dash2 and Biswa P. Chatterji2,*; 1. INTRODUCTION; 1.1. Methods for Preparation of Paclitaxel Nanoparticles; 1.1.1. CN1463969A; 1.1.2. CN101829061A; 1.2. Human Serum Albumin (HSA) Associated and Other Protein Associated and Functionalized Taxol® or Paclitaxel Nanoparticles as Drug Delivery Agents; 1.2.1. US6506405B1; 1.2.2. US8268348B2 and US20100112077A1
|
| 505 |
8 |
|
|a 1.2.3. WO1994018954A11.2.4. US20040092577A1; 1.2.5. US20090004118; 1.2.6. US20090226393; 1.2.7. US20100015051; 1.2.8. US20100303723; 1.2.9. WO2007034479; 1.3. Micelles, Emulsions and Liposomes as Drug Delivery Carriers for Paclitaxel; 1.3.1. US20150366806; 1.3.2. WO2009070761; 1.3.3. EP2494956 and EP2494957; 1.3.4. WO1994007484; 1.3.5. WO1996002247; 1.3.6. CN102772368A; 1.3.7. US5424073; 1.3.8. KR101612194; 1.3.9. US8663599B1; 1.4. Carbon Nanoparticles as Drug Delivery Agents for Cancer Chemotherapy; 1.4.1. EP3063091; 1.4.2. US20090087493; 1.4.3. KR20180016231; 1.4.4. CN104998261
|
| 505 |
8 |
|
|a 1.4.5. WO20140153341.5. Nanodevices for Paclitaxel Delivery to Cancer Cells; 1.5.1. US20100215724; 1.5.2. US20100303716; DISCUSSION; CURRENT & FUTURE DEVELOPMENTS; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Advanced Therapy in Cancer: Stimuli-Responsive Nanocarriers for On-Demand Drug Delivery; Azadeh Haeri*, Fatemeh Mehryab and Hamid R. Moghimi; 1. INTRODUCTION; 2. STIMULI-RESPONSIVE NANOCARRIERS; 3. EXTERNAL STIMULI-RESPONSIVE DRUG DELIVERY; 3.1. Temperature-Responsive Nanocarriers; 3.2. Magnetic Field-Responsive Nanocarriers
|
| 505 |
8 |
|
|a 3.3. Photo-Responsive Nanocarriers3.4. Ultrasound-Responsive Nanocarriers; 4. INTERNAL STIMULI-RESPONSIVE DRUG DELIVERY; 4.1. pH-Responsive Nanocarriers; 4.2. Enzyme-Responsive Nanocarriers; 4.3. Redox-Responsive Nanocarriers; 5. OTHER STIMULI-RESPONSIVE NANOCARRIERS; CONCLUSION; CURRENT & FUTURE DEVELOPMENTS; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; The Regulation and the Function of Autophagy in the Development and Behavior of Esophageal Cancers; Erdem Ayik* and Gulsum O. Elpek; 1. INTRODUCTION; 2. GENERAL ASPECTS OF AUTOPHAGY; 3. AUTOPHAGY IN CANCER
|
| 500 |
|
|
|a 3.1. AP in Malignant Transformation
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Cancer
|x Prevention.
|
| 650 |
|
0 |
|a Cancer
|x Research.
|
| 650 |
|
0 |
|a Cancer
|x Treatment.
|
| 650 |
|
0 |
|a Tumors.
|
| 650 |
|
2 |
|a Neoplasms
|
| 650 |
|
6 |
|a Cancer
|x Prévention.
|
| 650 |
|
6 |
|a Cancer
|x Recherche.
|
| 650 |
|
6 |
|a Cancer
|x Traitement.
|
| 650 |
|
6 |
|a Tumeurs.
|
| 650 |
|
7 |
|a Cancer
|x Prevention
|2 fast
|
| 650 |
|
7 |
|a Cancer
|x Research
|2 fast
|
| 650 |
|
7 |
|a Cancer
|x Treatment
|2 fast
|
| 650 |
|
7 |
|a Tumors
|2 fast
|
| 700 |
1 |
|
|a Zaman, Khurshid.
|
| 758 |
|
|
|i has work:
|a Topics in Anti-Cancer Research (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFrhqWR33fH7xqGMYrF4YP
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Rahman, Atta-ur.
|t Topics in Anti-Cancer Research: Volume 7.
|d Sharjah : Bentham Science Publishers, ©2018
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5614091
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5614091
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 15891928
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1981550
|
| 994 |
|
|
|a 92
|b IZTAP
|
